Home

Not a member? Sign up!

Forgot your password?

Selzentry

Added: November 15, 2007 | Time 01:00 | Views: 559

Selzentry, a new drug that has recently been approved by the FDA, blocks viral entry into white blood cells, significantly reducing viral load and increasing T-cell counts in treatment-experienced patients infected with a specific type of HIV.

Topics: HIV/AIDS, Infectious Disease

Tags: FDA, food and drug administration, hiv, selzentry, T-cells, viral load, white blood cells

Embed:

Comments

Post a Comment

Please log in at the top of the page to post a comment!

chicagogal says:42 weeks ago | Reply

This is great! A new HIV drug has been long in coming. Hope it works for most infected people.

Promo

Video Upload Tools

Popular Health Topics

Special Searches

Company Information

Site Links

Resources / Support

By using this service, you accept our Terms of Service. Please read them. The health information on this site is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen.